NGEN
NervGen Pharma Corp.
1.90$
+2.7%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | – | +99.3% | +1.2% | +8.1% | +165.7% | +27.1% | -42.3% | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | +751.4% | -7.3% | +12.1% | +138.6% | -51.3% | +95.7% | -11.2% | |
| – | – | – | – | – | – | +52.0% | -3.1% | +19.7% | |
| – | +11,034.6% | +656.4% | +10.8% | +15.1% | +76.5% | -22.3% | +40.8% | +1.0% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.